mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.3 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |